Invesco Funds - Invesco China Health Care Equity Fund R Fonds
4,37
EUR
-0,02
EUR
-0,46
%
NAV
Werbung
Werbung
Anlageziel
The Fund aims to achieve long term capital growth. The Fund seeks to achieve its objective by investing primarily in a concentrated portfolio of Chinese healthcare companies. Such companies will be listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect (which may include companies listed on the ChiNext Board or the Science and Technology Innovation (STAR) board) as well as those listed or traded elsewhere, included via QFI.
Stammdaten
| Name | Invesco Funds - Invesco China Health Care Equity Fund R EUR Acc Fonds |
| ISIN | LU2336016758 |
| WKN | A3CX6X |
| Fondsgesellschaft | Invesco Management S.A. |
| Benchmark | MSCI CHINA A ONSHORE/HEALTH CARE |
| Ausschüttungsart | Thesaurierend |
| Manager | Chris Liu, Kehong Jiang |
| Domizil | Luxembourg |
| Fondskategorie | Aktien |
| Auflagedatum | 26.05.2021 |
| Geschäftsjahr | 29.02. |
| VL-fähig? | Nein |
| Depotbank | Bank of New York Mellon S.A./N.V. |
| Zahlstelle | BNP Paribas Securities Services,Paris,succursale de Zurich |
| Riester Fonds | Nein |
Basisdaten
| Auflagedatum | 26.05.2021 |
| Depotbank | Bank of New York Mellon S.A./N.V. |
| Zahlstelle | BNP Paribas Securities Services,Paris,succursale de Zurich |
| Domizil | Luxembourg |
| Geschäftsjahr | 29.02. |
Aktuelle Daten
| Morningstar Rating | |
| Aktueller Rücknahmepreis | 4,37 |
| Anzahl Fonds der Kategorie | 780 |
| Volumen der Tranche | 192.363,73 EUR |
| Fondsvolumen | 50,53 Mio. EUR |
| Total Expense Ratio (TER) | 2,64 |
Gebühren
| Laufende Kosten | 3,94% |
| Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 2,64% |
| Transaktionskosten | 1,30% |
| Depotbankgebühr | - |
| Managementgebühr | 1,50% |
| Rücknahmegebühr | - |
| Ausgabeaufschlag | - |
Performancedaten
| Veränderung Vortag | -0,02 |
| WE seit Jahresbeginn | -6,42% |